William B. Stilley's most recent trade in Adial Pharmaceuticals Inc was a trade of 240,800 Common Stock done . Disclosure was reported to the exchange on May 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adial Pharmaceuticals Inc | William B. Stilley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 240,800 | 1,261,779 (12%) | 2% | 0 | Common Stock | |
| Adial Pharmaceuticals Inc | William B. Stilley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | William B. Stilley | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Dec 2022 | 166,667 | 1,020,979 (9%) | 1% | 0 | Common Stock | |
| Adial Pharmaceuticals Inc | William B. Stilley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 100,000 | 100,000 | - | - | Stock Options | |
| Adial Pharmaceuticals Inc | William B. Stilley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 250,000 | 1,187,646 (11%) | 2% | 0 | Common Stock | |
| Adial Pharmaceuticals Inc | William B. Stilley | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 29 Nov 2021 | 10,600 | 937,646 (9%) | 0% | 2.8 | 29,179 | Common Stock |
| Adial Pharmaceuticals Inc | William B. Stilley | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.59 per share. | 29 Nov 2021 | 10,000 | 927,046 (8%) | 0% | 2.6 | 25,892 | Common Stock |
| Adial Pharmaceuticals Inc | William B. Stilley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 250,000 | 250,000 | - | - | Employee Stock Option | |
| Adial Pharmaceuticals Inc | William B. Stilley | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 201,109 | 917,046 (8%) | 1% | - | Common Stock | |
| Avalon GloboCare Corp | William B. Stilley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Avalon GloboCare Corp | William B. Stilley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Avalon GloboCare Corp | William B. Stilley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 8,000 | 8,000 | - | - | Stock Option (right to buy) |